INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | - | ₹0.06 Cr | ₹0.07 Cr | ₹0.06 Cr | ₹1.38 Cr |
What is the latest Contingent Liabilities ratio of INNOVA CAPTAB ?
Year | Contingent Liabilities |
---|---|
Mar2024 | - |
Mar2023 | ₹0.06 Cr |
Mar2022 | ₹0.07 Cr |
Mar2021 | ₹0.06 Cr |
Mar2020 | ₹1.38 Cr |
How is Contingent Liabilities of INNOVA CAPTAB Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | - | -100.00 | |
Mar2023 | ₹0.06 Cr | -15.49 | |
Mar2022 | ₹0.07 Cr | 18.33 | |
Mar2021 | ₹0.06 Cr | -95.65 | |
Mar2020 | ₹1.38 Cr | - |
Compare Contingent Liabilities of peers of INNOVA CAPTAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INNOVA CAPTAB | ₹5,098.5 Cr | 0.5% | 0.7% | 85% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,076.0 Cr | 0.3% | -4.9% | 15.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,924.0 Cr | 0.2% | 10% | 53.5% | Stock Analytics | |
CIPLA | ₹121,456.0 Cr | 2.3% | 1.1% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,197.0 Cr | 5.7% | 15% | 11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,761.0 Cr | 0.8% | -0.9% | 17.4% | Stock Analytics |
INNOVA CAPTAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INNOVA CAPTAB | 0.5% |
0.7% |
85% |
SENSEX | 0.9% |
1.8% |
11.1% |
You may also like the below Video Courses